Cyclodextrin dimer with porphyrin core for target transport and combined therapy


    loading  Checking for direct PDF access through Ovid

Abstract

We tested beta- and gamma-cyclodextrin dimer with porphyrin core as a linker for target transport drugs (taxol and doxorubicin) and for combined therapy on nunu mice with skin cancer.

    loading  Loading Related Articles